Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-NDThe Lancet regional health. Southeast Asia

India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.

  • Sarbasree Bhattacharjee1
  • Jarina Begum1
  1. 1Manipal Tata Medical College, Manipal Academy of Higher Education, Manipal, India.
Read full textPDFDOICite

Related

  1. Beyond global AMR targets: toward equitable and actionable implementation targets in humanitarian settings
    Carine Naim, Krystel Moussally, Mohamad Khalife +6
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
  2. Integrative ALS therapy: gene targeted therapy by base editing and potential exercise rehabilitation as synergistic strategies for functional recovery
    Kwangjun Lee, Taejin Kwak, Wonil Park
    Physical activity and nutritionPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Jail-based opioid treatment implementation, outcomes, and costs: lessons learned from the Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)
    Elizabeth A. Evans, Thomas J. Stopka, Ekaterina Pivovarova +9
    Harm Reduction JournalPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  4. Evolution of CAR-T Therapy: Functional Engineering, Manufacturing Innovation, and Future In Vivo Strategies.
    Yukimi Sakoda
    Cancer sciencePeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Should ApoE4 gene editing therapy be approached with caution when AD is accompanied by retinal neurodegenerative diseases?
    Yi Wenhua, Ma Wenjing, Dai Yan +14
    Frontiers in neurologyPeer-reviewedCC BYFull textPhysiologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{bhattacharjee2026indias,
  title = {{India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.}},
  author = {Sarbasree Bhattacharjee and Jarina Begum},
  journal = {The Lancet regional health. Southeast Asia},
  year = {2026},
  month = oct,
  doi = {10.1016/j.lansea.2026.100883},
  url = {https://europepmc.org/article/MED/42894775},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.
AU  - Sarbasree Bhattacharjee
AU  - Jarina Begum
PY  - 2026
DA  - 2026/10/10
JO  - The Lancet regional health. Southeast Asia
DO  - 10.1016/j.lansea.2026.100883
UR  - https://europepmc.org/article/MED/42894775
SN  - 2772-3682
ER  -